TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34735963

Group type: EXPERIMENTAL
Intervention: Perampanel (PER) at doses of 8 mg and 12 mg/day
Number of subjects: 2187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2187

Group type: EXPERIMENTAL
Intervention: Perampanel (PER) at doses of 2 mg and 4 mg/day
Number of subjects: 2187
Study: 33938094

Group type: EXPERIMENTAL
Intervention: 12-week public health intervention based on self-efficacy theory and group process
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual services (control group)
Number of subjects: 68
Study: 32311925

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) treatment with a diode laser emitting at 808 nm, 100 mW, for 40 seconds per site, 20 sites irradiated weekly for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo PBM treatment
Number of subjects: 60
Study: 35460304

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) in addition to conventional symptomatic treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional symptomatic treatment
Number of subjects: 44
Study: 33721507

Group type: EXPERIMENTAL
Intervention: Sleep restriction (4 hours in bed)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control sleep (8 hours in bed)
Number of subjects: 10
Study: 34463768

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 106
Study: 34618482

Group type: EXPERIMENTAL
Intervention: Physical and/or sexual abuse treatment (PSA‐T)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Cognitive-behavioral SUD‐T (control group)
Number of subjects: 57
Study: 33870711

Group type: EXPERIMENTAL
Intervention: Potassium supplement (90 mmol/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 32682277

Group type: EXPERIMENTAL
Intervention: Fear-Specific Exposure (FSE)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Disgust-Specific Exposure (DSE)
Number of subjects: 57

Group type: COMPARATOR
Intervention: General Negative Exposure (GNE)
Number of subjects: 57
Study: 35306865

Group type: EXPERIMENTAL
Intervention: Multimedia education and nursing intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional education and routine breathing training (Control)
Number of subjects: 120
Study: 34789233

Group type: EXPERIMENTAL
Intervention: VUMIE™ (virtual microbiology simulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wetlab (traditional laboratory)
Number of subjects: 0
Study: 32320948

Group type: EXPERIMENTAL
Intervention: TF elastic band (BAND)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control condition (CON)
Number of subjects: 30
Study: 36271399

Group type: EXPERIMENTAL
Intervention: Educational outreach with audit and feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EHR-integrated clinical pathway decision support tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33873249

Group type: EXPERIMENTAL
Intervention: Modified yes/no condition (students solved six problems rewritten to answer a yes/no question)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Standard textbook condition (students solved a set of six word problems taken from current textbooks)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Disfluency control condition (students solved standard problems rewritten in unusual fonts)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: All conditions (after solving their assigned problems)
Number of subjects: 229
Study: 33191209

Group type: EXPERIMENTAL
Intervention: Faith-based (FB) intervention including BHT DSMES, Health Sermon, SMRC Diabetes Self-Management Program (DSMP), and 7-session Healthy Bible Study
Number of subjects: 360

Group type: COMPARATOR
Intervention: Faith-placed (FP) intervention including SMRC DSMP facilitated by outside health professional and 7-session community health and safety curriculum
Number of subjects: 360
Study: 33942179

Group type: EXPERIMENTAL
Intervention: Individual Model Averaging (IMA)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard Approach (STD)
Number of subjects: 1000
Study: 32087003

Group type: EXPERIMENTAL
Intervention: Minesapride 40 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Minesapride 120 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 48
Study: 34553614

Group type: EXPERIMENTAL
Intervention: Superficial dry needling (DN) in the upper trapezius
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Deep dry needling (DN) in the upper trapezius
Number of subjects: 180

Group type: COMPARATOR
Intervention: Simulated dry needling technique in the gastrocnemius muscle (control group)
Number of subjects: 180
Study: 33090946

Group type: EXPERIMENTAL
Intervention: High severity, intentional incident
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low severity, intentional incident
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High severity, accidental incident
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low severity, accidental incident
Number of subjects: 0
Study: 34916216

Group type: EXPERIMENTAL
Intervention: Margetuximab plus chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trastuzumab plus chemotherapy
Number of subjects: 0
Study: 32413915

Group type: EXPERIMENTAL
Intervention: Wet-suction technique
Number of subjects: 296

Group type: COMPARATOR
Intervention: Dry-suction technique
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Wet-suction technique (two passes)
Number of subjects: 296
Study: 35477634

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) ketamine (0.5 mg/kg, infused over 40 minutes)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Intranasal (IN) esketamine (56/84 mg)
Number of subjects: 63
Study: 34952814

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standing position
Number of subjects: 101
Study: 32303436

Group type: EXPERIMENTAL
Intervention: Edetate disodium chelation therapy (40 infusions of a 500 mL solution)
Number of subjects: 1708

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1708
Study: 32900605

Group type: EXPERIMENTAL
Intervention: Narrative-based educational video
Number of subjects: 365

Group type: COMPARATOR
Intervention: Pamphlet
Number of subjects: 365
Study: 35562695

Group type: EXPERIMENTAL
Intervention: Digital Behaviour Change Intervention (DBCI) - ePrimaPrescribe
Number of subjects: 47
Study: 35429354

Group type: EXPERIMENTAL
Intervention: Remote Trier Social Stress Test (rTSST)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 99
Study: 33472420

Group type: EXPERIMENTAL
Intervention: Web ORLA® (Oral Reading for Language in Aphasia)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (commercially available computer game)
Number of subjects: 32
Study: 32537276

Group type: EXPERIMENTAL
Intervention: Visceral mobilization (sphincter inhibition and mobilization of the large intestine)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Conventional physical therapy with visceral mobilization
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham procedure (superficial touching over the intestines)
Number of subjects: 30
Study: 35430325

Group type: EXPERIMENTAL
Intervention: Theta tACS (20 minutes) during daily multitasking training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delta tACS (20 minutes) during daily multitasking training
Number of subjects: 0
Study: 35175905

Group type: EXPERIMENTAL
Intervention: 6-month all-oral regimen including levofloxacin, bedaquiline, and linezolid
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard-of-care (SOC) ⩾9-month WHO-approved injectable-based regimen
Number of subjects: 111
Study: 34340406

Group type: EXPERIMENTAL
Intervention: RF mixing module integrated into room temperature control system
Number of subjects: 0
Study: 32001833

Group type: EXPERIMENTAL
Intervention: Intraperitoneal carboplatin (AUC = 6) and intravenous paclitaxel (80 mg/m2) administered on days 1, 8, and 15.
Number of subjects: 76
Study: 34080585

Group type: EXPERIMENTAL
Intervention: Life-style intervention
Number of subjects: 2675
Study: 32713466

Group type: EXPERIMENTAL
Intervention: Intravenous TXA (single preoperative dose)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (saline solution)
Number of subjects: 101
Study: 32686337

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg per day
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 34237385

Group type: EXPERIMENTAL
Intervention: Conservative access cavity (ConsAC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Truss access cavity (TrecAC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional access cavity (TradAC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (intact teeth)
Number of subjects: 40
Study: 34292119

Group type: EXPERIMENTAL
Intervention: Written consent
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Waiver of consent
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Assent by relative
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Witnessed verbal consent
Number of subjects: 3035
Study: 33310052

Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises (self-administered via CD for two menstrual cycles)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 124
Study: 35350864

Group type: EXPERIMENTAL
Intervention: Spinal anesthetic (SP)
Number of subjects: 199

Group type: COMPARATOR
Intervention: General anesthetic (GA) with femoral block
Number of subjects: 199
Study: 34282216

Group type: EXPERIMENTAL
Intervention: Rod monolateral external fixator with a distraction system
Number of subjects: 14

Group type: COMPARATOR
Intervention: Circular multi‐axis system
Number of subjects: 14
Study: 32209248

Group type: EXPERIMENTAL
Intervention: MenACYW-TT
Number of subjects: 1715

Group type: EXPERIMENTAL
Intervention: MenACYW-TT co-administered with Tdap and HPV4
Number of subjects: 1715

Group type: COMPARATOR
Intervention: MCV4-CRM
Number of subjects: 1715

Group type: COMPARATOR
Intervention: Tdap and HPV4 vaccines alone
Number of subjects: 1715
Study: 36341847

Group type: EXPERIMENTAL
Intervention: DREAM intervention (community health worker-led behavioral intervention)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Attention control condition
Number of subjects: 200
Study: 36254613

Group type: EXPERIMENTAL
Intervention: Self-guided self-compassion training
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Self-guided applied relaxation training
Number of subjects: 63
Study: 34432770

Group type: EXPERIMENTAL
Intervention: Cold Polypectomy (CP)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Hot Polypectomy (HP)
Number of subjects: 6
Study: 32857495

Group type: EXPERIMENTAL
Intervention: Doxycycline binding aptamers selected from a randomized library of tetracycline aptamer variants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorescence emission intensity of doxycycline upon aptamer binding
Number of subjects: 0
Study: 34558340

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy
Number of subjects: 18
Study: 34617974

Group type: EXPERIMENTAL
Intervention: Lifitegrast ophthalmic solution, 5.0%, twice daily for 84 days
Number of subjects: 1429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1429
Study: 33040702

Group type: EXPERIMENTAL
Intervention: Admission systolic blood pressure (SBP)
Number of subjects: 3180

Group type: EXPERIMENTAL
Intervention: Admission diastolic blood pressure (DBP)
Number of subjects: 3180

Group type: EXPERIMENTAL
Intervention: Admission blood pressure (SBP and DBP)
Number of subjects: 3180
Study: 33480963

Group type: EXPERIMENTAL
Intervention: Margetuximab (15 mg/kg) plus chemotherapy
Number of subjects: 536

Group type: COMPARATOR
Intervention: Trastuzumab (6 mg/kg, loading dose 8 mg/kg) plus chemotherapy
Number of subjects: 536
Study: 34907910

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus cobimetinib (combination arm)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Atezolizumab monotherapy (monotherapy arm)
Number of subjects: 77
Study: 33430845

Group type: EXPERIMENTAL
Intervention: Culturally situated peer group intervention (Tertulias)
Number of subjects: 0
Study: 35176046

Group type: EXPERIMENTAL
Intervention: School-based health promotion intervention including interactive learning sessions (30 minutes/week) and physical activity sessions (30 minutes, four times a week) for students; educational sessions for parents and teachers (30 minutes, four times during the intervention period).
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 360
Study: 33619917

Group type: EXPERIMENTAL
Intervention: Long-lasting permethrin impregnated (LLPI) socks
Number of subjects: 367

Group type: COMPARATOR
Intervention: General socks
Number of subjects: 367
Study: 32941462

Group type: EXPERIMENTAL
Intervention: Proactive electronic-consultation from pulmonologists recommending ICS discontinuation
Number of subjects: 9

Group type: COMPARATOR
Intervention: Unexposed providers' anticipation of patient resistance to ICS discontinuation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intervention-exposed providers' experiences post-intervention
Number of subjects: 9
Study: 35525420

Group type: EXPERIMENTAL
Intervention: Chrononutritional and sleep hygiene intervention
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual care for gestational diabetes mellitus
Number of subjects: 103
Study: 34409989

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 1051
Study: 36345138

Group type: EXPERIMENTAL
Intervention: +10% increased cadence
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ‐10% decreased cadence
Number of subjects: 48

Group type: COMPARATOR
Intervention: Preferred cadence
Number of subjects: 48
Study: 33951613

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 5594
Study: 32839161

Group type: EXPERIMENTAL
Intervention: GP-targeted educational intervention
Number of subjects: 224

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 224
Study: 35674828

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32338886

Group type: EXPERIMENTAL
Intervention: Ball milling grinding process
Number of subjects: 1

Group type: COMPARATOR
Intervention: Control (non-milled)
Number of subjects: 1
Study: 33166213

Group type: EXPERIMENTAL
Intervention: Cerebellar iTBS with physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham iTBS with physiotherapy
Number of subjects: 30
Study: 33052404

Group type: EXPERIMENTAL
Intervention: Recovering Together (RT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control
Number of subjects: 58
Study: 35013909

Group type: EXPERIMENTAL
Intervention: Caloric restriction
Number of subjects: 88

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 88

Group type: COMPARATOR
Intervention: Caloric restriction and exercise interaction
Number of subjects: 88

Group type: COMPARATOR
Intervention: Biomarker index correlation with physical performance
Number of subjects: 88

Group type: COMPARATOR
Intervention: Biomarker index reduction and walking speed
Number of subjects: 88
Study: 34371478

Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 32426759

Group type: EXPERIMENTAL
Intervention: Acute wild blueberry intervention
Number of subjects: 0
Study: 34092524

Group type: EXPERIMENTAL
Intervention: Posterior nasal neurectomy + pharyngeal neurectomy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Posterior nasal neurectomy
Number of subjects: 52
Study: 33789482

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 120
Study: 35260218

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics
Number of subjects: 109
Study: 33836161

Group type: EXPERIMENTAL
Intervention: Benznidazole 300 mg daily for 8 weeks
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Benznidazole 300 mg daily for 4 weeks
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Benznidazole 300 mg daily for 2 weeks
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Benznidazole 150 mg daily for 4 weeks
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Benznidazole 150 mg daily for 4 weeks plus fosravuconazole
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Benznidazole 300 mg weekly for 8 weeks plus fosravuconazole
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 32176245

Group type: EXPERIMENTAL
Intervention: Family member detention or deportation in the past year
Number of subjects: 547
Study: 616864697

Group type: EXPERIMENTAL
Intervention: Mannatide, oxaliplatin, and docetaxel sequential therapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Thymosin, oxaliplatin, and docetaxel sequential therapy
Number of subjects: 72
Study: 35703413

Group type: EXPERIMENTAL
Intervention: AI-assisted interpretation
Number of subjects: 390

Group type: COMPARATOR
Intervention: Non-AI-assisted interpretation
Number of subjects: 390
Study: 34116913

Group type: EXPERIMENTAL
Intervention: Onlay patellar resurfacing technique
Number of subjects: 222

Group type: COMPARATOR
Intervention: Inlay patellar resurfacing technique
Number of subjects: 222
Study: 32757822

Group type: EXPERIMENTAL
Intervention: Acupressure (rotary massage using the thumb at pressure points) for 4 weeks, 3 times a week for 20 minutes each session
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study: 35973032

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 139
Study: 34526081

Group type: EXPERIMENTAL
Intervention: Raw natural honey (0.5 g) and encapsulated organic Nigella sativa seeds (40 mg) per kg body weight per day
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo (empty capsule with 30 ml of 5% dextrose water)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Raw natural honey and Nigella sativa
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 32444057

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program, 8 two-hour group sessions once a week.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Routine consultation (Control group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program
Number of subjects: 36
Study: 36206399

Group type: EXPERIMENTAL
Intervention: Age increase by 10 years
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Therapy duration >= 1 year
Number of subjects: 100
Study: 35152767

Group type: EXPERIMENTAL
Intervention: Go NAPSACC intervention
Number of subjects: 3883
Study: 32143392

Group type: EXPERIMENTAL
Intervention: Brain Breaks® videos during classroom sessions for four months
Number of subjects: 3036

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 3036
Study: 34498386

Group type: EXPERIMENTAL
Intervention: BRAVA intervention
Number of subjects: 46
Study: 34444671

Group type: EXPERIMENTAL
Intervention: S. boulardii and Superoxide Dismutase (SOD) supplementation for 60 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 36387994

Group type: EXPERIMENTAL
Intervention: Online support program (monitoring app, confirmation app, writing app)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monitoring app (control group)
Number of subjects: 0
Study: 32282564

Group type: EXPERIMENTAL
Intervention: Acupressure on 6 acupoints administered at home every night for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group maintained their daily routine
Number of subjects: 0
Study: 34266843

Group type: EXPERIMENTAL
Intervention: Low-threshold unguided digital self-management tool (transdiagnostic mental health app)
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 1100
Study: 32088687

Group type: EXPERIMENTAL
Intervention: Infection control pathway (experimental group)
Number of subjects: 426
Study: 33608835

Group type: EXPERIMENTAL
Intervention: Warming at 42 °C after vitrification in sterile liquid air (LA42)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Warming at 45 °C after vitrification in sterile liquid air (LA45)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitrification in liquid nitrogen (LN) warmed at 42 °C
Number of subjects: 0
Study: 34781981

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (400 mg daily for the first four days, then 400 mg weekly)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo (same treatment schedule as hydroxychloroquine)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269

Group type: COMPARATOR
Intervention: Hydroxychloroquine and Placebo
Number of subjects: 269
Study: 32205067

Group type: EXPERIMENTAL
Intervention: OCT-guided PCI
Number of subjects: 38

Group type: COMPARATOR
Intervention: Angiography-guided PCI
Number of subjects: 38
Study: 35403573

Group type: EXPERIMENTAL
Intervention: Induction of labour in week 41
Number of subjects: 12

Group type: COMPARATOR
Intervention: Expectant management until week 42
Number of subjects: 12
Study: 32857730

Group type: EXPERIMENTAL
Intervention: Acupressure applied to P6 point, 3 times a day for 1 week
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 149
Study: 36078621

Group type: EXPERIMENTAL
Intervention: Elastic band resistance training (hip and chest regions)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Participant feedback on the PA interventions
Number of subjects: 23
Study: 36361372

Group type: EXPERIMENTAL
Intervention: READY-Nepal intervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 102
Study: 33579340

Group type: EXPERIMENTAL
Intervention: Neoadjuvant proton radiotherapy (39 Gy in 13 fractions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant carbon ion radiotherapy (39 Gy in 13 fractions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined treatment (neoadjuvant radiotherapy + surgery)
Number of subjects: 0
Study: 33007908

Group type: EXPERIMENTAL
Intervention: Social media
Number of subjects: 550

Group type: COMPARATOR
Intervention: Traditional media
Number of subjects: 550